Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors
Clinical trial NCT03386721 · TERMINATED
Trial details
- NCT number
- NCT03386721
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-19
- Primary completion
- 2021-12-30
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.